Hospital Clínic-IDIBAPS Treats Over 500 Cancer Patients with Academic CAR-T Therapy

Published on Spencer Knight via LinkedIn

Hospital Clínic Barcelona-IDIBAPS has become a European leader in academic CAR-T, treating over 500 patients since 2017 with two therapies approved in Spain: ARI-0001 for leukemia and ARI-0002 for multiple myeloma. Their decentralized model now enables treatment access across 13 hospitals in Spain.

With a 50% complete remission rate, their work demonstrates that non-commercial, public-sector innovation can deliver breakthrough outcomes. They are also developing CAR-T therapies for lymphoma and breast cancer. Spencer Knight calls it a powerful reminder of what’s possible with the right infrastructure and local empowerment.

Read the full article via El País:

👉 Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.